{"data":[{"accessionNo":"0001076809-26-000101","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000834365","issuerName":"BioLife Solutions, Inc.","ticker":"BLFS","cusip":"09062W204","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-09-17","reportingPerson":"Paul J. Glazer","reportingCik":null,"personType":"IN","sharesOwned":2685520,"percentOfClass":5.49,"filedAt":"2026-09-24"},{"accessionNo":"0001076809-26-000101","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000834365","issuerName":"BioLife Solutions, Inc.","ticker":"BLFS","cusip":"09062W204","securityClass":"Common stock, par value $0.001 per share","eventDate":"2026-09-17","reportingPerson":"Glazer Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":2685520,"percentOfClass":5.49,"filedAt":"2026-09-24"},{"accessionNo":"0001897612-26-000627","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000834365","issuerName":"BIOLIFE SOLUTIONS INC","ticker":"BLFS","cusip":"09062W204","securityClass":"COMMON STOCK","eventDate":"2026-08-31","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":3665965,"percentOfClass":7.5,"filedAt":"2026-09-08"},{"accessionNo":"0000919574-26-003837","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000834365","issuerName":"BIOLIFE SOLUTIONS INC","ticker":"BLFS","cusip":"09062W204","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-04","reportingPerson":"Eli Casdin","reportingCik":null,"personType":"IN","sharesOwned":4757165,"percentOfClass":9.7,"filedAt":"2026-06-04"},{"accessionNo":"0000919574-26-003837","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000834365","issuerName":"BIOLIFE SOLUTIONS INC","ticker":"BLFS","cusip":"09062W204","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-04","reportingPerson":"Casdin Partners GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":4757165,"percentOfClass":9.7,"filedAt":"2026-06-04"},{"accessionNo":"0000919574-26-003837","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000834365","issuerName":"BIOLIFE SOLUTIONS INC","ticker":"BLFS","cusip":"09062W204","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-04","reportingPerson":"Casdin Partners Master Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4757165,"percentOfClass":9.7,"filedAt":"2026-06-04"},{"accessionNo":"0000919574-26-003837","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000834365","issuerName":"BIOLIFE SOLUTIONS INC","ticker":"BLFS","cusip":"09062W204","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-04","reportingPerson":"Casdin Capital, LLC","reportingCik":null,"personType":"IA","sharesOwned":4757165,"percentOfClass":9.7,"filedAt":"2026-06-04"},{"accessionNo":"0000919574-26-003687","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0000834365","issuerName":"BIOLIFE SOLUTIONS INC","ticker":"BLFS","cusip":"09062W204","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-20","reportingPerson":"Eli Casdin","reportingCik":"0001534264","personType":"IN","sharesOwned":4757165,"percentOfClass":9.7,"filedAt":"2026-05-22"},{"accessionNo":"0000919574-26-003687","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0000834365","issuerName":"BIOLIFE SOLUTIONS INC","ticker":"BLFS","cusip":"09062W204","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-20","reportingPerson":"Casdin Partners GP, LLC","reportingCik":"0001534260","personType":"OO","sharesOwned":4757165,"percentOfClass":9.7,"filedAt":"2026-05-22"},{"accessionNo":"0000919574-26-003687","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0000834365","issuerName":"BIOLIFE SOLUTIONS INC","ticker":"BLFS","cusip":"09062W204","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-20","reportingPerson":"Casdin Partners Master Fund, L.P.","reportingCik":"0001534265","personType":"PN","sharesOwned":4757165,"percentOfClass":9.7,"filedAt":"2026-05-22"},{"accessionNo":"0000919574-26-003687","formType":"SCHEDULE 13D/A","amendmentNo":7,"issuerCik":"0000834365","issuerName":"BIOLIFE SOLUTIONS INC","ticker":"BLFS","cusip":"09062W204","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-05-20","reportingPerson":"Casdin Capital, LLC","reportingCik":"0001534261","personType":"IA","sharesOwned":4757165,"percentOfClass":9.7,"filedAt":"2026-05-22"},{"accessionNo":"0001897612-26-000472","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000834365","issuerName":"BIOLIFE SOLUTIONS INC","ticker":"BLFS","cusip":"09062W204","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":6506346,"percentOfClass":13.5,"filedAt":"2026-05-15"},{"accessionNo":"0000914208-26-000113","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0000834365","issuerName":"BioLife Solutions Inc","ticker":"BLFS","cusip":"09062W204","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Invesco Ltd.","reportingCik":null,"personType":"HC,IA","sharesOwned":2348532,"percentOfClass":4.9,"filedAt":"2026-05-06"},{"accessionNo":"0000102909-26-000788","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000834365","issuerName":"BioLife Solutions Inc","ticker":"BLFS","cusip":"09062W204","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26"},{"accessionNo":"0000914208-26-000046","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000834365","issuerName":"BioLife Solutions Inc","ticker":"BLFS","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Invesco Ltd.","reportingCik":null,"personType":"HC,IA","sharesOwned":3932191,"percentOfClass":8.2,"filedAt":"2026-02-12"},{"accessionNo":"0001897612-26-000006","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000834365","issuerName":"BIOLIFE SOLUTIONS INC","ticker":"BLFS","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"T. Rowe Price Investment Management, Inc.","reportingCik":null,"personType":"IA","sharesOwned":5180824,"percentOfClass":10.8,"filedAt":"2026-01-08"},{"accessionNo":"0000919574-25-006181","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0000834365","issuerName":"BioLife Solutions, Inc.","ticker":"BLFS","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-10-15","reportingPerson":"Casdin Capital, LLC","reportingCik":"0001534261","personType":"IA","sharesOwned":5957165,"percentOfClass":12.4,"filedAt":"2025-10-17"},{"accessionNo":"0000919574-25-006181","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0000834365","issuerName":"BioLife Solutions, Inc.","ticker":"BLFS","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-10-15","reportingPerson":"Casdin Partners Master Fund, L.P.","reportingCik":"0001534265","personType":"PN","sharesOwned":5957165,"percentOfClass":12.4,"filedAt":"2025-10-17"},{"accessionNo":"0000919574-25-006181","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0000834365","issuerName":"BioLife Solutions, Inc.","ticker":"BLFS","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-10-15","reportingPerson":"Casdin Partners GP, LLC","reportingCik":"0001534260","personType":"OO","sharesOwned":5957165,"percentOfClass":12.4,"filedAt":"2025-10-17"},{"accessionNo":"0000919574-25-006181","formType":"SCHEDULE 13D/A","amendmentNo":6,"issuerCik":"0000834365","issuerName":"BioLife Solutions, Inc.","ticker":"BLFS","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-10-15","reportingPerson":"Eli Casdin","reportingCik":"0001534264","personType":"IN","sharesOwned":5957165,"percentOfClass":12.4,"filedAt":"2025-10-17"}],"updatedAt":"2026-10-15T01:50:38.140Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}